Kim Christopher

2.2

2.2

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Apimeds Pharmaceuticals US Inc (APUS)

Transaction date 14 May 2025

Purchase

Price

224.18

Quantity 90,388 +44.1%

Value US$4,914,605

Comments Filing

Apimeds Pharmaceuticals US Inc (APUS)

Transaction date 13 May 2025

Purchase

Price

219.15

Quantity 88,194 -20.8%

Value US$3,104,080

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-05-15	2025-05-14	Apimeds Pharmaceuticals US Inc (APUS)	B Purchase	90,388 +44.1% 224.18 US$4,914,605	90,388 +44.1%	224.18	US$4,914,605
2025-05-15	2025-05-13	Apimeds Pharmaceuticals US Inc (APUS)	B Purchase	88,194 -20.8% 219.15 US$3,104,080	88,194 -20.8%	219.15	US$3,104,080